| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | general cells |
IFO50036 |
P388D1 |
mouse |
lymph node |
lymphoid neoplasm, derived from P388, (DBA/2 mouse) |
|
| 2 | general cells |
IFO50074 |
HFL1 |
human |
lung |
Normal diploid fibroblasts with limited life span. |
|
| 3 | general cells |
IFO50221 |
N18-RE-105 |
mouse x rat |
|
Neuron like cells established from mouse N18TG2 x Fischer rat 18 day-embryonic neural retina. |
|
| 4 | general cells |
IFO50416 |
3T3-L1 |
mouse |
embryo |
3T3 L1 cell line is a substrain of 3T3-Swiss albino cell line. 3T3 L1 cells convert adipose-like cells at confluent. |
|
| 5 | general cells |
JCRB0121 |
YG10008 |
hamster, Chinese |
lung |
human polymorphic N-acetyltransferase gene transfected CHL cells |
|
| 6 | general cells |
JCRB0143.2 |
F2408 EBNA2 cl-16 |
rat |
whole body of embryo |
F2408 cell line transfected with recombinant plasmid pZE2 with coding region of the EBNA2 and the expression of the EBNA2 was strong in this strain. |
|
| 7 | general cells |
JCRB0727 |
A9(An4)-2 |
human chromosome-introduced |
hybrid |
contains human chromosome # 1 (MTA with Tottori Univ. is required.) |
|
| 8 | general cells |
JCRB1012 |
KMRC-3 |
human |
kidney |
Human tumor cell line from kidney. Clear cell renal carcinoma cell line. The growth is extremely slow. |
|
| 9 | general cells |
JCRB1138 |
NRG |
mouse |
Bone marrow |
Osteoblastic cell line of mouse C3H. |
|
| 10 | general cells |
JCRB1149 |
UE6E7T-11 |
human |
bone marrow |
Human bone marrow-derived mesenchymal stem cells. |
|
| 11 | general cells |
JCRB1204 |
KUM7 |
mouse |
Bone marrow |
Osteoblastic cell line |
|
| 12 | general cells |
JCRB1351 |
Int-3LL |
mouse |
|
Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL). |
|
| 13 | general cells |
JCRB1358.03 |
SRBC-P20-13-13 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
| 14 | general cells |
JCRB1361 |
Vn1919 |
mouse |
brain |
neuroglial and neuronal character coexpressing ependymoma cell line. |
|
| 15 | general cells |
JCRB1416 |
KasumiA-554 |
human |
blood |
myeloid leukemia secondary to ATL |
|
| 16 | genetically-modified cells |
JCRB1517 |
POLK F171A MSH- |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH-, POLK KO/F171A, TK+/+) |
|
| 17 | genetically-modified cells |
JCRB1545 |
EM-E6/E7/hTERT-2 |
human |
uterine endometrium |
Immortalized human uterine endometril progenitor cell line. |
|
| 18 | general cells |
JCRB1634 |
VV-B2D10 |
mouse x mouse |
|
Mouse hybridoma producing mAb to hemagglutinine (HA) of vaccinia virus |
|
| 19 | general cells |
JCRB1795 |
BALM-16 |
human |
peripheral blood |
B cell leukemia cell line, Ig negative, ALL-L3 cell line, t(8;22)(q24;q11), hypercalcemia, mRNA expression of PTHrP |
|
| 20 | general cells |
JCRB1806 |
PIS-1 |
human |
lung |
Human pulmonary intimal sarcoma |
|
| 21 | general cells |
JCRB2202 |
A9(Neo2) |
human chromosome-introduced |
skin |
contains human chromosome # 2 (MTA with Tottori Univ. is required.) |
|
| 22 | general cells |
JCRB2219 |
A9(Neo19) |
human chromosome-introduced |
skin |
contains human chromosome #19 (MTA with Tottori Univ. is required.) |
|
| 23 | general cells |
JCRB2222 |
A9(Hygro22) |
human chromosome-introduced |
skin |
contains human chromosome #22 (MTA with Tottori Univ. is required.) |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.